Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 10-K/A Report 10-K/A
  5. 4 Open-market sale Senior VP, Chief Pharma Dev. sold 10,000 shares at an average $273.24 ($2,732,438)
  6. 8-K Event Results of operations
  7. 10-K Report Annual Report
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Open-market sale Director sold 22,489 shares at an average $293.15 ($6,592,686)
  18. 4 Grant or award Chief Commercial Officer acquired 15,001 shares (grant or award)
  19. 4 Grant or award Senior VP, Chief Pharma Dev. acquired 5,667 shares (grant or award)
  20. 4 Grant or award SVP and General Counsel acquired 15,001 shares (grant or award)

Page 19 of 62 · 1,224 filings